Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system

被引：1
|
作者：
Luo, Qian [1 ,2 ,3 ]
Yang, Jiaying [2 ,3 ]
Yang, Mei [2 ,3 ]
Wang, Yingtong [4 ]
Liu, Yiran [1 ]
Liu, Jixuan [2 ,3 ]
Kalvakolanu, Dhan, V [5 ]
Cong, Xianling [1 ]
Zhang, Jinnan [1 ]
Zhang, Ling [2 ,3 ]
Guo, Baofeng [1 ]
Duo, Yanhong [6 ]
机构：
[1] Jilin Univ, China Japan Union Hosp, Dept Plast Surg, Changchun 130033, Peoples R China
[2] Jilin Univ, Coll Basic Med Sci, Key Lab Pathobiol, Minist Educ, Changchun 130021, Peoples R China
[3] Jilin Univ, Coll Basic Med Sci, Dept Biomed Sci, Changchun 130021, Peoples R China
[4] Jilin Univ, Hosp Stomatol, Undergraduate Ctr, Changchun 130021, Peoples R China
[5] Univ Maryland, Greenebaum NCI Comprehens Canc Ctr, Sch Med, Dept Microbiol & Immunol, Baltimore, MD USA
[6] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA
来源：
MATERIALS TODAY BIO | 2025年 / 31卷
基金：
中国国家自然科学基金;
关键词：
Nanoscale delivery platforms; Nano-sized particles; Disorders of the central nervous system; Cerebrovascular barrier; ENHANCED DRUG-DELIVERY; SILICA NANOPARTICLES; PARKINSONS-DISEASE; IN-VITRO; GOLD NANOPARTICLES; LOADED LIPOSOMES; TUMOR BARRIER; GENE DELIVERY; GLIOBLASTOMA; THERAPY;
D O I：
10.1016/j.mtbio.2025.101457
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
Central nervous system (CNS) diseases are a major cause of disability and death worldwide. Due to the bloodbrain barrier (BBB), drug delivery for CNS diseases is extremely challenging. Nano-delivery systems can overcome the limitations of BBB to deliver drugs to the CNS, improve the ability of drugs to target the brain and provide potential therapeutic methods for CNS diseases. At the same time, the choice of different drug delivery methods (bypassing BBB or crossing BBB) can further optimize the therapeutic effect of the nano-drug delivery system. This article reviews the different methods of nano-delivery systems to overcome the way BBB enters the brain. Different kinds of nanoparticles to overcome BBB were discussed in depth.
引用
收藏
页数：32
相关论文
共 50 条
  • [31] Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders
    Xiao, Minjia
    Xiao, Zhi Jie
    Yang, Binbin
    Lan, Ziwei
    Fang, Fang
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [32] Microglia in the Neurovascular Unit: Blood-Brain Barrier-microglia Interactions After Central Nervous System Disorders
    Thurgur, Hannah
    Pinteaux, Emmanuel
    NEUROSCIENCE, 2019, 405 : 55 - 67
  • [33] Central nervous system complications of diabetes mellitus - A perspective from the blood-brain barrier
    Mooradian, AD
    BRAIN RESEARCH REVIEWS, 1997, 23 (03) : 210 - 218
  • [34] Involvement of noncoding RNA in blood-brain barrier integrity in central nervous system disease
    Liu, Xi
    Shen, Ling
    Han, Bing
    Yao, Honghong
    NON-CODING RNA RESEARCH, 2021, 6 (03): : 130 - 138
  • [35] Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery
    Alavijeh M.S.
    Chishty M.
    Qaiser M.Z.
    Palmer A.M.
    NeuroRX, 2005, 2 (4): : 554 - 571
  • [36] Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma
    Galor, Anat
    Ference, Sandra J.
    Singh, Arun D.
    Lee, Michael S.
    Stevens, Glen H. J.
    Perez, Victor L.
    Peereboom, David M.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 144 (01) : 45 - 49
  • [37] Examining the Uptake of Central Nervous System Drugs and Candidates across the Blood-Brain Barrier
    Summerfield, Scott G.
    Zhang, Yanyan
    Liu, Houfu
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 358 (02): : 294 - 305
  • [38] Complement activation in the central nervous system following blood-brain barrier damage in man
    Lindsberg, PJ
    Ohman, J
    Lehto, T
    KarjalainenLindsberg, ML
    Paetau, A
    Wuorimaa, T
    Carpen, O
    Kaste, M
    Meri, S
    ANNALS OF NEUROLOGY, 1996, 40 (04) : 587 - 596
  • [39] Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma
    Goldstein, Debra A.
    Tessler, Howard H.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 144 (06) : 976 - 976
  • [40] Pathways for Small Molecule Delivery to the Central Nervous System Across the Blood-Brain Barrier
    Mikitsh, John L.
    Chacko, Ann-Marie
    PERSPECTIVES IN MEDICINAL CHEMISTRY, 2014, 6 : 11 - 24
12345